Profile of cognitive progression in early Huntington’s disease
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective: To examine the pattern of cognitive decline in early Huntington’s disease (HD).
Methods: The authors studied 61 patients with mild to moderate HD who had at least three annual neuropsychological assessments using the Core Assessment Program for Intracerebral Transplantation in Huntington’s Disease short battery. A subset of 34 patients had additional neuropsychological tests, and another subset of 21 patients was assessed annually on the Cambridge Neuropsychological Test Automated Battery. Neuropsychological measures that changed significantly over time were submitted to a multiple analysis of covariance to explore associations with demographic and neurologic indices.
Results: Patients showed a progressive impairment in attention, executive function, and immediate memory, with timed tests of psychomotor skill being particularly sensitive to decline. In contrast, general cognition, semantic memory, and delayed recall memory were relatively unaffected.
Conclusion: The profile of cognitive performance shows selective and progressive dysfunction of attention and executive function in patients with mild to moderate HD, consistent with frontostriatal pathology at this stage of disease.
Most early studies to delineate the cognitive deficits of Huntington’s disease (HD) typically adopted a cross-sectional approach1–3⇓⇓ using various criteria and different boundaries for subgroup staging to infer the pattern of decline. The extrapolation of such findings to applied settings, such as treatment trials, can only be tentative and so longitudinal studies are clearly needed to better establish the time course and specific profile of cognitive decline in HD.3,4⇓
In a longitudinal study of 14 patients with HD,5 letter fluency, vocabulary, and selective reminding performance declined over a 12-month period, but not confrontation naming, number information, similarities, category fluency, or visual reproduction. A follow-up study of 6 patients with HD over 3 to 5.8 years3 suggested that tests involving psychomotor skill deteriorated markedly over time, as did performance tests from the Wechsler Adult Intelligence Scale (WAIS) battery, with academic skills being less affected. More recently, larger longitudinal studies have shown that although global cognitive ability does not appear to deteriorate,6,7⇓ tests that tap attention or executive function tend to undergo progressive impairment7–9⇓⇓ although this was not found in all studies.6 There are also other discrepancies between studies; for example, letter fluency has been reported to deteriorate,5,7,9⇓⇓ improve,6 or remain stable8 in HD. Similarly, with verbal memory there is evidence for deterioration,8,9⇓ improvement,6 or no change.7,9⇓ Language or semantic functions may (e.g., picture naming7,8⇓) or may not (e.g., comprehension7) deteriorate depending on the nature of the task used. Thus there is a need for a comprehensive battery of appropriate neuropsychological tests to be performed longitudinally on large numbers of relatively homogenous patients with HD. These multiple conditions are not easy to fulfill, especially given the unavoidable patient attrition rate in longitudinal paradigms of any considerable period of time. Therefore we examined the natural history of cognitive impairment in a large cohort of patients with mild to moderate HD using a comprehensive battery of neuropsychological tests.
Method.
Participants.
Sixty-one patients were enrolled in this ethically approved multicenter (Aberdeen, Belfast, Cambridge, Cardiff, Manchester, Innsbruck, and Leiden) study and gave informed consent to participate. Of these 61 patients, 4 were randomly selected at a later date for fetal neural transplantation in a small-scale UK-based safety trial using this technique. The data presented from these four patients were collected before this operation. Therefore all participants in this study are representative of patients with HD at the early stage of disease.
All patients had mild to moderate HD according to the motor and functional subscales of the Unified Huntington’s Disease Rating Scale (UHDRS)10 (see the table for clinical characteristics), such a level being defined by a baseline independence score of between 70 to 100, with clearcut signs of HD on physical examination. Patients were excluded if there was any other concurrent neurologic illness or if they were receiving medication at entry to the study. It was possible to select such a group of medication-free patients because they were recruited from a number of centers. Over the time course of the study, individual clinicians were permitted to treat mild psychiatric symptoms and thus some patients were later placed on medication. However, a record of these data was not part of the study and thus these data were not available.
Table Clinical characteristics (mean ± sd) of patients with Huntington’s disease (HD)
The 61 patients with HD had at least three annual motor assessments and administrations of the Core Assessment Program for Intracerebral Transplantation in Huntington’s Disease (CAPIT-HD) short battery; 34 of these also had two administrations of the CAPIT-HD baseline tests and 21 had at least three administrations of the Cambridge Neuropsychological Test Automated Battery (CANTAB) (Cambridge Cognition, Cambridge, UK). A summary of the patients’ clinical characteristics and follow-up duration for each neuropsychological battery is provided in the table. Patients in each of these three test groups had similar clinical characteristics, indicating that the subgroups were representative of the entire cohort. All motor and cognitive (see below) assessments were carried out by appropriately trained and experienced personnel. Inter-rater reliability was not performed especially given that these standardized tests are well validated and are in common practice.
Neuropsychological assessment.
These assessments (CAPIT-HD short battery and CAPIT-HD baseline tests) were carried out in two 1- to 2-hour sessions on either the same or consecutive days and alternate equivalent forms of tests were used whenever available. Where the CANTAB battery was administered, an extra 60- to 90-minute session was required. The tests comprising the various assessment batteries11 are provided below, in order of administration. Tests with alternate forms are marked with an asterisk (*).
CAPIT-HD baseline tests.
CAPIT-HD baseline tests included the following: 1) WAIS-Revised (WAIS-R) vocabulary subtest12; 2) WAIS-R block design subtest12; 3) *National Adult Reading Test,13 Dutch version (Nederlandse Leestest voor Volwassenen14) or German equivalent (Mehrfachwahl-Wortschatz-Intelligenztest15); 4) Visual Object and Space Perception battery16; 5) *Boston Naming Test17; and 6) Token Test18-short form.
CAPIT-HD short battery.
CAPIT-HD short battery included the following: 1) verbal (letter) fluency19; 2) *Rivermead Behavioral Memory Test Battery (RBMT)20—the Story Recall Test assessed immediately and after a 20-minute delay; 3) *Symbol Digit Modalities Test21; 4) Stroop Test22; 5) Folstein Mini-Mental State Examination (MMSE)23; 6) Conditional Associative Learning Test24—participants learn the arbitrary pairings between two sets of objects by a process of trial and error; a maximum of 68 trials is allowed, and the learning criterion is 12 successive correct responses; 7) *Hopkins Verbal Learning Test (HVLT)25—participants provide immediate and delayed (20-minute) recall of a list of 12 words over three trials; 8) Modified Wisconsin Card Sorting Test (WCST)26—the Nelson short form; 9) *Reitan Trail Making Test27; 10) *Digit Span12—forwards and backwards; 11) verbal (semantic-category) fluency28; and 12) Forward Spatial Span.29
CANTAB test battery.
For the CANTAB test battery,4,30⇓ the following tests are conducted on a computer with a touch-sensitive screen.
-
Pattern and Spatial Recognition Memory. These two tasks evaluate recognition memory for abstract patterns and spatial locations separately. Correct recognition and average response times were measured.
-
Intra dimensional/extra dimensional (ID/ED) set shifting task. Participants are required to learn a nine-stage series of two-alternative forced-choice discriminations using feedback provided by the computer. At the ED shift, which is similar to a category change on the WCST, novel exemplars of the two dimensions are presented and participants should now shift “response set” to the previously irrelevant stimulus dimension and ignore the previously relevant dimension. The number of stages passed, average error, and average latency were recorded.
-
Match to Sample Visual Search. In this search task for designated patterns, reaction time, movement time, and total correct responses were recorded.
-
Spatial Working Memory. This examines memory for locations already visited. A lower strategy score indicated that participants searched through the boxes using a more efficient strategy to find tokens. The between search error score reflects the number of times participants returned to a previously inspected box on the same trial.
-
One-touch Tower of London. This modified version of the CANTAB Tower of London task is based on the original Tower of London Task. Participants were instructed to determine the number of minimum moves necessary to make one arrangement identical to the model arrangement without actually moving any of the balls. The total accuracy score was calculated based on the choices made; a higher score indicated greater impairment.
Statistical analysis.
Because there were several missing data points, the number of patients analyzed for each test is specified in tables E-1, E-2, and E-3 on the Neurology Web site (www.neurology.org).
To examine the overall pattern of longitudinal decline, individual regression slopes for each patient were fitted for each test. A linear regression model was used with time as the independent variable and patient test performance as the dependent variable. For the CAPIT-HD short battery and CANTAB battery, all patients had at least three data points and so it was believed that the data would be best represented by regression line slopes that would measure decline over the entire follow-up period. This would capture the data fully and minimize the impact of interindividual and intraindividual variability that is common in these patients.7 For the CAPIT-HD baseline tests, difference scores were analyzed because data were collected at two time points. In accordance with other studies of longitudinal decline, p values were not adjusted for multiple comparisons.7 We adopted this approach in order to minimize Type II error, because the objective was to increase sensitivity for detecting performance change. As a consequence, it is possible that some of these p values may be inflated. Exact p values for all tests are provided in tables E-1, E-2, and E-3 on the Neurology Web site (www.neurology.org).
Those neuropsychological measures that significantly changed over time were then submitted to a multiple analysis of covariance (MANCOVA) in order to investigate if these measures were associated with demographic (sex, mode of inheritance, age at onset, duration of HD) and neurologic indices (linear regression slopes over consecutive assessments for the UHDRS total motor score, Total Functional Assessment score, Total Functional Capacity, and Independence Scale).
Results.
All changes in performance over time referred to below are significant at at least the p < 0.05 level. For details of test results see tables E-1, E-2, and E-3 on the Neurology Web site (www.neurology.org).
Although general cognition as assessed by the MMSE did not change over time, the specific subscores for time orientation, place orientation, and delayed recall were progressively impaired, but the decline was slight, as reflected by the respective mean slopes (see table E-1 at www.neurology.org). In contrast, all tests of attention and executive function were found to deteriorate except for the WCST (where there was actually a decrease of the percentage of Milner perseverative errors). Measures such as Stroop (color naming and word reading) and Trails (A and B) showed a relatively marked decline over time as evidenced by a steeper regression slope, while verbal fluency (letter and semantic category), Symbol Digit Modalities, and Stroop interference declined to a lesser degree.
From the CAPIT-HD baseline tests, only Block Design and the Token Test deteriorated over time (see table E-2, www.neurology.org). CANTAB test measures that declined over time were the total accuracy score for the one-touch Tower of London, and mean latency for the set shifting task and pattern recognition memory (see table E-3, www.neurology.org).
When all the neuropsychological measures that decreased or increased over time were included in a MANCOVA to explore possible associations with demographic (sex, mode of inheritance, age at onset, duration of HD) and neurologic variables (linear regression slopes over consecutive assessments for the UHDRS motor score, Total Functional Capacity, and Independence Scale), two significant relationships emerged. First, duration of disease (estimated historically) was negatively associated with Pattern Recognition (CANTAB battery) mean latency (p < 0.01), such that longer duration of disease was accompanied by slower performance on this task. Secondly, Total Functional Assessment score was positively associated with the one-touch Tower of London (CANTAB battery) accuracy score (p < 0.01), such that poorer functional scores occurred together with poorer planning ability.
Discussion.
This study examined the pattern of cognitive decline in the largest cohort of patients with mild to moderate HD so far reported who received a comprehensive battery of neuropsychological tests.
Virtually all tests of attention and executive function deteriorated over a 3- to 6-year period, providing strong evidence for early and pervasive executive function decline over time as suggested in cross-sectional studies.1,2⇓ In addition, it consolidates previous longitudinal studies showing a decline in subsets of executive function tests using either smaller cohorts5,7,9⇓⇓ or fewer tests.8
An examination of the rate of decline (mean slopes from tables E-2, E-3, and E-4 at www.neurology.org) of various executive function tests revealed that this was not uniform. Specifically, tests that tapped psychomotor skill—i.e., Trails A (mean slope = 0.43), Stroop word reading (mean slope = −0.34), Stroop color naming (mean slope = −0.20), and Symbol digit modalities (mean slope = −0.12)—were prone to some of the highest levels of decline. Previously, timed psychomotor tests have been found to be particularly sensitive to longitudinal change3,7–9⇓⇓⇓ because they are affected by mental processing and motor function, which are necessary for accurate and fast performance. Nevertheless, it did not appear that tests more reliant on motor skill always suffered a greater degree of decline because the symbol digit substitution test was not as sensitive as Stroop word reading and color naming. These simpler Stroop measures may be sensitive to decline8,9⇓ owing to the basal ganglia contribution in the fluent generation of highly automatic over-learnt sequences.9 Trails B, which taps cognitive flexibility (in addition to psychomotor ability), showed an even greater degree of decline (mean slope = 2.02) than tests of psychomotor skill, suggesting that the additional requirement of holding and switching mental sets makes this test even more sensitive than purely psychomotor measures.
Next, more traditional tests of executive function that tapped planning showed the greatest rate of decline. Patients were increasingly impaired in their ability to correctly plan the minimum number of moves required to make the test array identical to a target array on the one-touch Tower of London test (strategy score mean slope = 0.08). While patients did not show a clearcut impairment in the ID/ED set shifting and Spatial Working Memory tasks, a decline in mental processing speed and psychomotor speed was suggested by the increased average response latency. The absence of a clearcut decline is not unexpected given that tasks that are dependent on the use of strategy often have limited test-retest reliability. Indeed, the results on the WCST (in which there was no change, apart from less Milner perseverative errors) reflected this, and supports previous research suggesting that this test is not ideal for longitudinal assessment in HD.7,9⇓
Next, tests of lexical retrieval showed smaller but significant rates of decline, with both phonemic (mean slope = −0.06) and semantic category (mean slope = −0.05) fluency being equally affected, suggesting a frontal access difficulty rather than an amnesic degradation of lexical storage.
Finally, tests of attentional span (i.e., spatial span, digit span forwards and backwards) declined at the lowest rate but still to a significant extent. Tests that tap immediate memory (therefore requiring adequate attention and concentration) also declined, such as the Token Test7 and some subsections of the MMSE (i.e., time orientation, place orientation, delayed recall). This latter subsection of the MMSE actually involves a very short delay of not more than a couple of minutes at the most, and is therefore strictly an immediate memory task. Likewise, the Token Test is reliant on immediate memory to correctly execute verbal instructions. This decline in immediate memory is likely to stem from an attentional impairment, in view of the concurrent attentional/executive deficits demonstrated in this cohort. In contrast, measures of delayed memory (over a longer period of time) generally remained stable (i.e., for a word list [HVLT] and narrative [RBMT]). Similarly, visuospatial (consistent with some studies1,31⇓ but not others2,32⇓) and semantic memory measures such as word naming and vocabulary showed no progressive decline (supporting some studies3,32,33⇓⇓ but not others7,8,34⇓⇓).
This consistent and selective deterioration of attentional/executive function is compatible with the frontostriatal pathology of patients at the mild to moderate stage of HD. In the earlier stages of HD, pathology begins in the dorsal caudate nucleus, which forms part of the dorsolateral prefrontal cortex loop, and from there gradually spreads throughout the frontostriatal system.35 Both structural and functional imaging studies have shown that impairments in executive function tasks early in HD relate to this frontostriatal neuropathology,36,37⇓ and this includes presymptomatic HD gene carriers. For example, impairment in accuracy on the one-touch Tower of London test of planning has been shown to correlate with loss of caudate and putamen D2 receptor binding potentials in HD.4 Therefore the selective attentional and executive function decline in patients with early to moderate HD found in this study is entirely consistent with the reported pathophysiologic changes described previously at this stage of disease. It is likely that other cognitive functions such as delayed recall memory and semantic knowledge are affected only when the disease progresses beyond this point with involvement of nonfrontal areas, especially the hippocampal complex and temporal lobes.
In terms of correlating cognitive deficits to disease duration, the rate of decline for the mean latency for pattern recognition memory was associated, suggesting that lower performance on this measure is associated with longer duration of HD symptoms. This lends some support to the notion that visuospatial measures are sensitive to the progression of cognitive impairment although it may not be a prominent feature of early HD.2,32⇓ The relevance of cognitive deficits to activities of daily living was evident in that a significant relationship was found between the Total Functional Assessment subsection of the UHDRS and executive function (i.e., the strategy score for the one-touch Tower of London task). This suggests that cognitive ability to direct attention and plan rather than motor performance was related to the ability to perform functional everyday activities successfully.38
Finally, our findings suggest that fractionation of executive processes may provide a clearer picture of cognitive change in HD. However, disentangling component executive processes and types of tests is not a straightforward matter, and it could be that timed measures may be even more sensitive to longitudinal change due to the finer scale of measurement.7 Nevertheless, we identified tests that are most sensitive at detecting longitudinal changes in early HD, which may be of value in better understanding the pathophysiologic changes at this stage of disease and in monitoring novel disease-modifying pharmacologic or surgical interventions.
Appendix
Members of the NEST-HD Consortium: A.E. Rosser, MRCP, PhD (University of Cardiff); S.B. Dunnett, DSc (University of Cardiff); J.D. Pickard, MChir, FMedSci (University of Cambridge); R.A.C. Roos, MD, PhD (Leiden University); D. Craufurd, FRCPsych (University of Manchester); P.J. Morrison, MD (Belfast City Hospital); S.A. Simpson, MD (University of Aberdeen); T. Benke, MD (University of Innsbruck); G. Berrios, MD, FRCPsych, FMedSci (University of Cambridge); N. Kennedy, MRCPsych (University of Cambridge); A.C. Wagle, MD, MRCPsych (University of Cambridge); N. Chada, MD (South Tyrone Hospital, Belfast); P. Harper, FRCP (University of Wales School of Medicine, Cardiff); R. Harper, MRCPsych (University of Wales School of Medicine, Cardiff); D.J. Brooks, MD (MRC Cyclotron Unit, Hammersmith Hospital, London); P. Piccini, MD (MRC Cyclotron Unit, Hammersmith Hospital, London); N. Pavese, MD (MRC Cyclotron Unit, Hammersmith Hospital, London).
Disclosure
B.J. Sahakian is a consultant for Cambridge Cognition, distributors of the CANTAB battery.
Acknowledgments
A.K. Ho is supported by the MRC trials grant G9825903 to A.E. Rosser, S.B. Dunnett, R.A. Barker, and J.D. Pickard (ISCRTN no: 36485475). This work was funded by the Medical Research Council, The Wellcome Trust (Programme Grant Number 019407 to T.W. Robbins, B.J. Everitt, A.C. Roberts, and B.J. Sahakian), the Huntington’s Disease Association, and the British Brain and Spine Foundation.
The authors thank T.W. Robbins for comments on the manuscript; S. Kaptoge (CAMS) for advice on statistical analyses; A. Lawrence, L. Watkins, S. Rahman, R. Holt, and A. Krijnen for their contribution towards the testing of patients over the years; J. Lucas and A. Kershaw for patient care; and P. Como for help and support in developing the original battery.
Footnotes
-
Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the December 23 issue to find the title link for this article.
-
↵*Coordinators of the CAPIT-HD Neuropsychology Working Group and writing committee.
-
↵‡Members of the CAPIT-HD Neuropsychology Working Group and writing committee.
-
↵§Members of the NEST-HD Consortium are listed in the Appendix on page 1705.
- Received March 27, 2002.
- Accepted August 19, 2003.
References
- ↵
- ↵
- ↵
- ↵
Lawrence AD, Hodges JR, Rosser AE, et al. Evidence for specific cognitive deficits in preclinical Huntington’s disease. Brain. 1998; 121 (Pt 7): 1329–1341.
- ↵
Hodges JR, Salmon DP, Butters N. Differential impairment of semantic and episodic memory in Alzheimer’s and Huntington’s diseases: a controlled prospective study. J Neurol Neurosurg Psychiatry. 1990; 53: 1089–1095.
- ↵
Kremer B, Clark CM, Almqvist EW, et al. Influence of lamotrigine on progression of early Huntington disease: a randomized clinical trial. Neurology. 1999; 53: 1000–1011.
- ↵
Bachoud-Levi AC, Maison P, Bartolomeo P, et al. Retest effects and cognitive decline in longitudinal follow-up of patients with early HD. Neurology. 2001; 56: 1052–1058.
- ↵
Bamford KA, Caine ED, Kido DK, Cox C, Shoulson I. A prospective evaluation of cognitive decline in early Huntington’s disease: functional and radiographic correlates. Neurology. 1995; 45: 1867–1873.
- ↵
- ↵
- ↵
- ↵
Wechsler D. Wechsler Adult Intelligence Scale—Revised manual. New York: Psychological Corporation, 1981.
- ↵
Nelson H. National Adult Reading Test (NART): test manual. Windsor: NFER-Nelson, 1982.
- ↵
- ↵
- ↵
Warrington E, James M. Visual Object and Space Perception Battery. Bury St Edmunds: Thames Valley Test Co., 1991.
- ↵
Kaplan E, Goodglass H, Weintraub S. The Boston Naming Test. Boston: Kaplan and Goodglass, 1978.
- ↵
De Renzi E, Faglioni P. Normative data and screening power of a shortened version of the Token Test. Cortex. 1978; 14: 41–49.
- ↵
Benton A. Differential behavioural effects in frontal lobe disease. Neuropsychologia. 1968; 6: 53–60.
- ↵
Wilson B, Cockburn J, Baddeley A. The Rivermead Behavioural Memory Test. Bury St Edmunds: Thames Valley Test Co., 1985.
- ↵
Smith A. The Symbol Digit Modalities Test: a neuropsychologic test for economic screening of learning and other cerebral disorders. Learning Disorders. 1968; 3: 83–91.
- ↵
- ↵
- ↵
- ↵
Brandt J. The Hopkins Verbal Learning Test: development of a new memory test with six equivalent forms. Clin Neuropsychol. 1991; 5: 125–142.
- ↵
- ↵
- ↵
- ↵
Milner B. Interhemispheric differences in the localisation of psychological processes in man. Br Med Bull. 1971; 27: 272–277.
- ↵
Robbins TW, James M, Owen AM, Sahakian BJ, McInnes L, Rabbitt P. Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia. 1994; 5: 266–281.
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
Sanchez-Pernaute R, Kunig G, del Barrio Alba A, de Yebenes JG, Vontobel P, Leenders KL. Bradykinesia in early Huntington’s disease. Neurology. 2000; 54: 119–125.
- ↵
- ↵
Marder K, Zhao H, Myers RH, et al. Rate of functional decline in Huntington’s disease. Huntington Study Group. Neurology. 2000; 54: 452–458.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Babak Hooshmand and Dr. David Smith
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Clinical manifestations of intermediate allele carriers in Huntington diseaseEsther Cubo, María A. Ramos-Arroyo, Saul Martinez-Horta et al.Neurology, July 08, 2016 -
Null Hypothesis
Clinical manifestations of homozygote allele carriers in Huntington diseaseEsther Cubo, Saul-Indra Martinez-Horta, Frederic Sampedro Santalo et al.Neurology, March 13, 2019 -
Special Article
Evidence-based guideline: Pharmacologic treatment of chorea in Huntington diseaseReport of the Guideline Development Subcommittee of the American Academy of NeurologyMelissa J. Armstrong, Janis M. Miyasaki et al.Neurology, July 18, 2012 -
Articles
Tetrabenazine as antichorea therapy in Huntington diseaseA randomized controlled trialHuntington Study Group et al.Neurology, February 13, 2006